573 related articles for article (PubMed ID: 30674868)
1. Increased expression of lncRNA CASC9 promotes tumor progression by suppressing autophagy-mediated cell apoptosis via the AKT/mTOR pathway in oral squamous cell carcinoma.
Yang Y; Chen D; Liu H; Yang K
Cell Death Dis; 2019 Jan; 10(2):41. PubMed ID: 30674868
[TBL] [Abstract][Full Text] [Related]
2. Loss of the clock gene Per1 promotes oral squamous cell carcinoma progression via the AKT/mTOR pathway.
Yang G; Yang Y; Tang H; Yang K
Cancer Sci; 2020 May; 111(5):1542-1554. PubMed ID: 32086839
[TBL] [Abstract][Full Text] [Related]
3. Long non-coding RNA CASC9 promotes tumor progression in oral squamous cell carcinoma by regulating microRNA-545-3p/laminin subunit gamma 2.
Ning B; Guo S; Mei Y
Bioengineered; 2021 Dec; 12(1):7907-7919. PubMed ID: 34612783
[TBL] [Abstract][Full Text] [Related]
4. LncRNA FOXD2-AS1 promotes the growth, invasion and migration of OSCC cells by regulating the MiR-185-5p/PLOD1/Akt/mTOR pathway.
Liu J; Zhang Y; Wu J; Liu X; Li L; Zhang J
Cancer Genet; 2024 Jun; 284-285():48-57. PubMed ID: 38729078
[TBL] [Abstract][Full Text] [Related]
5. Increased expression of lncRNA FTH1P3 promotes oral squamous cell carcinoma cells migration and invasion by enhancing PI3K/Akt/GSK3b/ Wnt/β-catenin signaling.
Liu M; Gao X; Liu CL
Eur Rev Med Pharmacol Sci; 2018 Dec; 22(23):8306-8314. PubMed ID: 30556871
[TBL] [Abstract][Full Text] [Related]
6. Assessment of multiple pathways involved in the inhibitory effect of HCG22 on oral squamous cell carcinoma progression.
Wang M; Feng Z; Li X; Sun S; Lu L
Mol Cell Biochem; 2021 Jun; 476(6):2561-2571. PubMed ID: 33649984
[TBL] [Abstract][Full Text] [Related]
7. LncRNA GACAT1 targeting miRNA-149 regulates the molecular mechanism of proliferation, apoptosis and autophagy of oral squamous cell carcinoma cells.
Chen J; Chen X; Fu L; Chen J; Chen Y; Liu F
Aging (Albany NY); 2021 Aug; 13(16):20359-20371. PubMed ID: 34460438
[TBL] [Abstract][Full Text] [Related]
8. CircRNA_002178 promotes the proliferation and migration of oral squamous cell carcinoma cells by activating the Akt/mTOR pathway.
Yang Y; Ci HS; Mao YL; Li JW; Zuo JH
Eur Rev Med Pharmacol Sci; 2020 Jun; 24(11):6122-6130. PubMed ID: 32572877
[TBL] [Abstract][Full Text] [Related]
9. A novel lncRNA LOLA1 may predict malignant progression and promote migration, invasion, and EMT of oral leukoplakia via the AKT/GSK-3β pathway.
Liu W; Yao Y; Shi L; Tang G; Wu L
J Cell Biochem; 2021 Oct; 122(10):1302-1312. PubMed ID: 33969929
[TBL] [Abstract][Full Text] [Related]
10. Urolithin A, induces apoptosis and autophagy crosstalk in Oral Squamous Cell Carcinoma via mTOR /AKT/ERK1/2 pathway.
Remadevi V; Jaikumar VS; Vini R; Krishnendhu B; Azeez JM; Sundaram S; Sreeja S
Phytomedicine; 2024 Jul; 130():155721. PubMed ID: 38788395
[TBL] [Abstract][Full Text] [Related]
11. The biological clock gene PER1 affects the development of oral squamous cell carcinoma by altering the circadian rhythms of cell proliferation and apoptosis.
Yin S; Zhang Z; Tang H; Yang K
Chronobiol Int; 2022 Sep; 39(9):1206-1219. PubMed ID: 35678317
[TBL] [Abstract][Full Text] [Related]
12. Up-regulation of lncRNA CASC9 promotes esophageal squamous cell carcinoma growth by negatively regulating PDCD4 expression through EZH2.
Wu Y; Hu L; Liang Y; Li J; Wang K; Chen X; Meng H; Guan X; Yang K; Bai Y
Mol Cancer; 2017 Aug; 16(1):150. PubMed ID: 28854977
[TBL] [Abstract][Full Text] [Related]
13. Overexpression of lncRNA HOXA-AS2 promotes the progression of oral squamous cell carcinoma by mediating SNX5 expression.
Li Z
BMC Mol Cell Biol; 2022 Dec; 23(1):59. PubMed ID: 36528556
[TBL] [Abstract][Full Text] [Related]
14. Low expression of lncRNA MEG3 promotes the progression of oral squamous cell carcinoma by targeting miR-21.
Zhang LL; Hu D; Zou LH
Eur Rev Med Pharmacol Sci; 2018 Dec; 22(23):8315-8323. PubMed ID: 30556872
[TBL] [Abstract][Full Text] [Related]
15. LncRNA CASC9 promotes esophageal squamous cell carcinoma metastasis through upregulating LAMC2 expression by interacting with the CREB-binding protein.
Liang Y; Chen X; Wu Y; Li J; Zhang S; Wang K; Guan X; Yang K; Bai Y
Cell Death Differ; 2018 Nov; 25(11):1980-1995. PubMed ID: 29511340
[TBL] [Abstract][Full Text] [Related]
16. Knockdown of RABL3 suppresses the proliferation and invasion of oral squamous cell carcinoma through inactivating the FAK/AKT pathway.
Xu Z; Li H; Lin C; Zeng B; Chen Y; Luo Y
J Bioenerg Biomembr; 2021 Apr; 53(2):203-211. PubMed ID: 33438143
[TBL] [Abstract][Full Text] [Related]
17. Overexpression of T-cadherin inhibits the proliferation of oral squamous cell carcinoma through the PI3K/AKT/mTOR intracellular signalling pathway.
Wang Q; Zhang X; Song X; Zhang L
Arch Oral Biol; 2018 Dec; 96():74-79. PubMed ID: 30195142
[TBL] [Abstract][Full Text] [Related]
18. Down-regulation of lncRNA OGFRP1 induces autophagy and growth inhibition by AKT/mTOR signaling pathway in HCAECs.
Zhang X; Liu J; Gu Y; Sun C; Qu F
Cell Biol Int; 2019 Feb; 43(2):158-166. PubMed ID: 30536541
[TBL] [Abstract][Full Text] [Related]
19. Honokiol inhibits in vitro and in vivo growth of oral squamous cell carcinoma through induction of apoptosis, cell cycle arrest and autophagy.
Huang KJ; Kuo CH; Chen SH; Lin CY; Lee YR
J Cell Mol Med; 2018 Mar; 22(3):1894-1908. PubMed ID: 29363886
[TBL] [Abstract][Full Text] [Related]
20. CircCDR1as upregulates autophagy under hypoxia to promote tumor cell survival via AKT/ERK
Gao L; Dou ZC; Ren WH; Li SM; Liang X; Zhi KQ
Cell Death Dis; 2019 Oct; 10(10):745. PubMed ID: 31582727
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]